Phuong N. Huynh

Array ( [id] => 4820553 [patent_doc_number] => 20080226667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Innate immune system-directed vaccines' [patent_app_type] => utility [patent_app_number] => 12/004344 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 24142 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226667.pdf [firstpage_image] =>[orig_patent_app_number] => 12004344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4928007 [patent_doc_number] => 20080167370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'MULTIDRUG MULTILIGAND CONJUGATES FOR TARGETED DRUG DELIVERY' [patent_app_type] => utility [patent_app_number] => 11/959947 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5103 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167370.pdf [firstpage_image] =>[orig_patent_app_number] => 11959947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552757 [patent_doc_number] => 20090286743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Methods and Compositions for Treating Conditions of the Eye' [patent_app_type] => utility [patent_app_number] => 11/945150 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13196 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286743.pdf [firstpage_image] =>[orig_patent_app_number] => 11945150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8027421 [patent_doc_number] => 08142791 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Multi-modal cancer therapy using viral hitch-hiking' [patent_app_type] => utility [patent_app_number] => 12/516530 [patent_app_country] => US [patent_app_date] => 2007-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 11193 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/142/08142791.pdf [firstpage_image] =>[orig_patent_app_number] => 12516530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446058 [patent_doc_number] => 20090047284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Methods and compositions for PDGF-C activation and inhibition' [patent_app_type] => utility [patent_app_number] => 11/985984 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15542 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047284.pdf [firstpage_image] =>[orig_patent_app_number] => 11985984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904667 [patent_doc_number] => 20080114081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Methods for diagnosis and treatment of PH domain signal transduction disorders' [patent_app_type] => utility [patent_app_number] => 11/984415 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22186 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114081.pdf [firstpage_image] =>[orig_patent_app_number] => 11984415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493722 [patent_doc_number] => 07947280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Apelin and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/985460 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 36203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947280.pdf [firstpage_image] =>[orig_patent_app_number] => 11985460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6440694 [patent_doc_number] => 20100104511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'METHODS AND COMPOSITIONS USING CHELATOR-ANTIBODY CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/516172 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17242 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104511.pdf [firstpage_image] =>[orig_patent_app_number] => 12516172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314281 [patent_doc_number] => 20100111963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD FOR TREATING AGE-RELATED MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 12/514445 [patent_app_country] => US [patent_app_date] => 2007-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12855 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111963.pdf [firstpage_image] =>[orig_patent_app_number] => 12514445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778290 [patent_doc_number] => 20080286288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => utility [patent_app_number] => 11/980495 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 101192 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286288.pdf [firstpage_image] =>[orig_patent_app_number] => 11980495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954099 [patent_doc_number] => 20110034448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'CARBONIC ANHYDRASE INHIBITOR SUSTAINED RELEASE INTRAOCULAR DRUG DELIVERY SYSTEMS' [patent_app_type] => utility [patent_app_number] => 11/931769 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26245 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034448.pdf [firstpage_image] =>[orig_patent_app_number] => 11931769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765077 [patent_doc_number] => 20080176288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Recombinant Production of Polyanionic Polymers, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/928737 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15050 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176288.pdf [firstpage_image] =>[orig_patent_app_number] => 11928737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954942 [patent_doc_number] => 20080187966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Antibodies and methods for making and using them' [patent_app_type] => utility [patent_app_number] => 11/928201 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 39699 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187966.pdf [firstpage_image] =>[orig_patent_app_number] => 11928201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903547 [patent_doc_number] => 20080112960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'MN/CA IX and EGFR Pathway Inhibition' [patent_app_type] => utility [patent_app_number] => 11/927150 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18457 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112960.pdf [firstpage_image] =>[orig_patent_app_number] => 11927150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824918 [patent_doc_number] => 20080124321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'ISOLATED BOVINE IgG HEAVY CHAIN PROTEIN AND ITS USE AS AN ANTIMICROBIAL' [patent_app_type] => utility [patent_app_number] => 11/926488 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3119 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124321.pdf [firstpage_image] =>[orig_patent_app_number] => 11926488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322872 [patent_doc_number] => 20090060862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'PEGylation by the Dock and Lock (DNL) Technique' [patent_app_type] => utility [patent_app_number] => 11/925408 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8952 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060862.pdf [firstpage_image] =>[orig_patent_app_number] => 11925408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304392 [patent_doc_number] => 20090299044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression' [patent_app_type] => utility [patent_app_number] => 11/978104 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 128 [patent_no_of_words] => 109445 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20090299044.pdf [firstpage_image] =>[orig_patent_app_number] => 11978104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5584992 [patent_doc_number] => 20090104194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'BI-DIRECTIONAL ANTIBODY FOR TREATMENT OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/876124 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1463 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104194.pdf [firstpage_image] =>[orig_patent_app_number] => 11876124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6118606 [patent_doc_number] => 20110076279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'FULLY HUMAN ANTI-VEGF ANTIBODIES AND METHODS OF USING' [patent_app_type] => utility [patent_app_number] => 12/446438 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15052 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20110076279.pdf [firstpage_image] =>[orig_patent_app_number] => 12446438 [rel_patent_id] =>[rel_patent_doc_number] =>)